NO20083636L - Asykliske sulfamid-derivater - Google Patents
Asykliske sulfamid-derivaterInfo
- Publication number
- NO20083636L NO20083636L NO20083636A NO20083636A NO20083636L NO 20083636 L NO20083636 L NO 20083636L NO 20083636 A NO20083636 A NO 20083636A NO 20083636 A NO20083636 A NO 20083636A NO 20083636 L NO20083636 L NO 20083636L
- Authority
- NO
- Norway
- Prior art keywords
- sulfamide derivatives
- acyclic
- acyclic sulfamide
- useful
- derivatives
- Prior art date
Links
- -1 Acyclic sulfamide derivatives Chemical class 0.000 title abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 210000000577 adipose tissue Anatomy 0.000 abstract 1
- 230000033228 biological regulation Effects 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 230000037356 lipid metabolism Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000036186 satiety Effects 0.000 abstract 1
- 235000019627 satiety Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/04—Diamides of sulfuric acids
- C07C307/06—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
Abstract
Den foreliggende oppfinnelsen er relatert til asykliske sulfamidderivater, nyttig for fremstillingen av et medikament for metthetsinduksjon og inntakskontroll, legemlig fettmodulering og lipidmetabolismeregulering og for fremstillingen av et medikament for behandlingen eller forebyggingen av diabetes og kardiovaskulæresykdommer. De asykliske sulfamid-derivatene er også nyttige for kosmetisk anvendelse.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200600184A ES2288107B1 (es) | 2006-01-27 | 2006-01-27 | Derivados aciclicos saturados e insaturados de cadena larga de sulfamidas como activadores especificos de receptores ppar-alfa. |
PCT/EP2007/000681 WO2007085469A1 (en) | 2006-01-27 | 2007-01-26 | Acyclic sulfamide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20083636L true NO20083636L (no) | 2008-08-25 |
Family
ID=37898592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20083636A NO20083636L (no) | 2006-01-27 | 2008-08-25 | Asykliske sulfamid-derivater |
Country Status (13)
Country | Link |
---|---|
US (1) | US8188312B2 (no) |
EP (1) | EP1984326B1 (no) |
JP (1) | JP2009524614A (no) |
KR (1) | KR20080109738A (no) |
CN (1) | CN101395130A (no) |
AU (1) | AU2007209465A1 (no) |
CA (1) | CA2640141A1 (no) |
ES (1) | ES2288107B1 (no) |
MX (1) | MX2008009590A (no) |
NO (1) | NO20083636L (no) |
NZ (1) | NZ570701A (no) |
RU (1) | RU2008134883A (no) |
WO (1) | WO2007085469A1 (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2389416B1 (es) * | 2011-03-30 | 2013-09-16 | Fundación Instituto Mediterraneo Para El Avance De La Biotecnología Y La Investigación Sanitaria (Imabis) | Uso de derivados de sulfamidas como neuroprotectores. |
JP5746988B2 (ja) * | 2012-02-15 | 2015-07-08 | ライオン株式会社 | カプセル皮膜及びカプセル |
JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
CN107141238A (zh) * | 2017-06-16 | 2017-09-08 | 吴宁怡 | 一种马西替坦中间体的制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3772207A (en) | 1971-09-09 | 1973-11-13 | Nalco Chemical Co | Process and compositions for controlling foaming in aqueous systems |
DE2729213C2 (de) * | 1977-06-29 | 1985-09-12 | Agfa-Gevaert Ag, 5090 Leverkusen | Farbfotografisches Aufzeichnungsmaterial |
US4218357A (en) * | 1977-06-29 | 1980-08-19 | General Electric Company | Plasticized polycarbonate composition |
US4252951A (en) * | 1979-10-09 | 1981-02-24 | Eli Lilly And Company | Isolation of syn-7-(2-amino-4-thiazolyl)-(methoxyimino)acetamido-3-acetoxymethyl-3-cephem-4-carboxylic acid |
US20050054730A1 (en) * | 2001-03-27 | 2005-03-10 | The Regents Of The University Of California | Compounds, compositions and treatment of oleoylethanolamide-like modulators of PPARalpha |
-
2006
- 2006-01-27 ES ES200600184A patent/ES2288107B1/es not_active Expired - Fee Related
-
2007
- 2007-01-26 NZ NZ570701A patent/NZ570701A/en not_active IP Right Cessation
- 2007-01-26 EP EP07703065.8A patent/EP1984326B1/en active Active
- 2007-01-26 CN CNA2007800071950A patent/CN101395130A/zh active Pending
- 2007-01-26 CA CA002640141A patent/CA2640141A1/en not_active Abandoned
- 2007-01-26 MX MX2008009590A patent/MX2008009590A/es active IP Right Grant
- 2007-01-26 US US12/162,035 patent/US8188312B2/en not_active Expired - Fee Related
- 2007-01-26 RU RU2008134883/04A patent/RU2008134883A/ru not_active Application Discontinuation
- 2007-01-26 JP JP2008551729A patent/JP2009524614A/ja not_active Abandoned
- 2007-01-26 WO PCT/EP2007/000681 patent/WO2007085469A1/en active Application Filing
- 2007-01-26 AU AU2007209465A patent/AU2007209465A1/en not_active Abandoned
- 2007-01-26 KR KR1020087020941A patent/KR20080109738A/ko not_active Application Discontinuation
-
2008
- 2008-08-25 NO NO20083636A patent/NO20083636L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1984326B1 (en) | 2017-05-03 |
AU2007209465A1 (en) | 2007-08-02 |
US20100048712A2 (en) | 2010-02-25 |
CN101395130A (zh) | 2009-03-25 |
ES2288107B1 (es) | 2008-11-01 |
NZ570701A (en) | 2010-10-29 |
MX2008009590A (es) | 2008-11-28 |
US20090221710A1 (en) | 2009-09-03 |
JP2009524614A (ja) | 2009-07-02 |
AU2007209465A8 (en) | 2008-10-02 |
US8188312B2 (en) | 2012-05-29 |
CA2640141A1 (en) | 2007-08-02 |
ES2288107A1 (es) | 2007-12-16 |
WO2007085469A1 (en) | 2007-08-02 |
RU2008134883A (ru) | 2010-03-10 |
EP1984326A1 (en) | 2008-10-29 |
US20100179224A2 (en) | 2010-07-15 |
KR20080109738A (ko) | 2008-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2217596B8 (en) | Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 | |
UA94734C2 (ru) | ТЕРАПЕВТИЧЕСКОЕ АНТИТЕЛО, КОТОРОЕ СВЯЗЫВАЕТСЯ С b-АМИЛОИДНЫМ ПЕПТИДОМ | |
WO2009068689A3 (en) | Combination of protein tyrosine phosphatase inhibitors and human growth hormone for the treatment of muscle atrophy and related disorders | |
EA200601777A1 (ru) | Новое применение пептидных соединений для лечения боли при болезненной диабетической нейропатии | |
WO2007136679A3 (en) | Targeting vegf-b regulation of fatty acid transporters to modulate human diseases | |
WO2008008286A3 (en) | Substituted pyrazoles as ghrelin receptor antagonists | |
BRPI0818079B8 (pt) | composição de lipídeo | |
MX2009002196A (es) | Oblea de buprenorfina para terapia de sustitucion de farmacos. | |
TW201712023A (en) | Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups | |
WO2011127304A3 (en) | Methods of treating an overweight subject | |
EA200971053A1 (ru) | Способы лечения кожных язв | |
WO2005115446A3 (en) | Detection and use of prolylcarboxypeptidase | |
TW200612903A (en) | Use of trisubstituted benzopyranones | |
ATE413167T1 (de) | Neuartige biaromatische ppar-rezeptoren aktivierende zusammensetzungen und ihre verwendung in kosmetischen oder pharmazeutischen zusammensetzungen | |
IL194237A0 (en) | Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators | |
TW200706182A (en) | Combination immediate release controlled release levodopa and carbidopa dosage forms | |
MX2009012922A (es) | Vacunacion intradermica de un peptido del virus del papiloma humano. | |
EA201100623A1 (ru) | Сульфоксиминзамещенные анилинопиримидиновые производные в качестве cdk ингибиторов, их получение и применение в качестве лекарственных средств | |
EP2010179A4 (en) | SUBSTITUTED IMIDAZOLE-4-CARBOXAMIDES AS CHOLECYSTOKININ-1-RECEPTOR MODULATORS | |
ATE457729T1 (de) | Verwendung von allopurinol zur behandlung von palmarer/plantarer erythrodysästhesie | |
ATE554076T1 (de) | Sulfoximinsubstituierte chinazolinderivate als immunmodulatoren, ihre herstellung und ihre verwendung als medikamente | |
EP2010178A4 (en) | SUBSTITUTED IMIDAZOLE-4-CARBOXAMIDES AS CHOLECYSTOKININ-1-RECEPTOR MODULATORS | |
NO20083636L (no) | Asykliske sulfamid-derivater | |
WO2009099553A3 (en) | Use of kinase inhibitor in treatment of atherosclerosis | |
BRPI0811347A2 (pt) | "extrato herbáceo medicinal dotado de efeito antiobesidade" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |